Genetic testing and sports medicine ethics

Sports Medicine

Volumn 39, Issue 5, 2009, Pages 339-344

  McNamee, Michael John ^a   Müller, Arno ^b   Van Hilvoorde, Ivo ^c   Holm, Søren ^d  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 3; APOLIPOPROTEIN E4;

FAMILY ASSESSMENT; GENE EXPRESSION; GENETIC SCREENING; GENOTYPE; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MEDICOLEGAL ASPECT; PROFESSIONAL SECRECY; REVIEW; SPORTS MEDICINE;

EID: 65949083996     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200939050-00001     Document Type: Review

References (34)

1. Genetic Technologies. Sports Performance ACTN3 Sports Gene Test® 2006 [online]. Available from URL: http://www.gtg.com.au/archives/migration/2/110/ 383/ACTN3%20web%20brochure.pdf [Accessed 2009 Feb 27]0
2. The Human Genetics Society of Australasia. HGSA position statement on genetic testing and sport performance. Alexandria: The Human Genetics Society of Australasia, 2007
3. Williams AG, Wackerhage H, Miah A, et al. Genetic research and testing in sport and exercise science: British Association of Sport and Exercise Sciences position stand [online]. Available from URL: http://www.bases.org.uk/newsite/ pdf/BASES [Accessed 2007 Sep 15]
4. Savulescu J, Foddy B. Comment: genetic test available for sports performance. Br J SportsMed 2005 Aug 1; 39 (8): 472
5. Miah A, Rich E. Genetic tests for ability? Talent identification and the value of an open future. Sport Educ Soc 2006;11 (3): 259-73
6. Munthe C. Selected champions: making winners in the age of genetic technology. In: Tamburrini CT, Tännsjö T, editor. Values in sport: elitism, nationalism, gender equality and the scientific manufacture of winners. London: Taylor and Francis, 2000: 217-31
7. Munthe C. Ethical aspects of controlling genetic doping. In: Tamburrini C, Tä nnsjö T, editors. The genetic technology and sport: ethical questions. London: Routledge, 2005: XII, 223 S
8. Murray TH. Assessing genetic technologies: two ethical issues. Int J Technol Assess Health Care 1994 Fall; 10 (4): 573-82
9. MaronBJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart 2005 Nov; 91 (11): 1380-2
10. Corrado D, Thiene G. Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm 2007; 4 (4): 520-4
11. Pelliccia A, Fagard R, Bjrnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26 (14): 1422-45
12. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002 Mar 13; 287 (10): 1308-20
13. Maron BJ. Sudden death in young athletes. N Engl J Med 2003 Sep 11; 349 (11): 1064-75
14. Council of Europe. Convention for the Protection ofHuman Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Oviedo: The Council of Europe, 1997
15. H.R.493-110th Congress, 2008. Genetic Information Nondiscrimination Act of 2008: an act to prohibit discrimination on the basis of genetic information with respect to health insurance and employment [online]. Available from URL: http://www.govtrack.us/congress/billtext.xpd?bill=h110 [Accessed 2008 Oct 3]
16. Johnson R. The unique ethics of sports medicine. Clin Sports Med 2004; 23 (2): 175-82
17. Dunn WR, George MS, Churchill L, et al. Ethics in sports medicine. Am J Sports Med 2007 May 1; 35 (5): 840-4
18. Waddington I, Malcolm D, Roderick M, et al. Drug use in English professional football. Br J Sports Med 2005 April 1; 39 (4): e18
19. Rankinen T, Bray MS, Hagberg JM, et al. The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc 2006 Nov; 38 (11): 1863-88
20. Unal M, Ozer Unal D. Gene doping in sports. Sports Med 2004; 34 (6): 357-6221. Miah A. Genetically modified athletes: biomedical ethics, gene doping and sport. London: Routledge, 2004
21. Clayton EW. Ethical, legal, and social implications of genomicmedicine.NEngl J Med 2003 Aug 7; 349 (6): 562-9
22. Yang N, MacArthur DG, Gulbin JP, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003 Sep; 73 (3): 627-31
23. Lucia A, Olivan J, Gomez-Gallego F, et al. Citius and longius (faster and longer) with no alpha-actinin-3 in skeletal muscles? Br J Sports Med 2007 Sep; 41 (9): 616-7
24. Roth SM. ACTN3 was never 'the' gene for speed. Br J Sports Med 2007 Sep 24 (electronic letter) [online]. Available from URL: http://bjsm.bmj.com/cgi/ eletters/41/9/616#1707 [Accessed 2008 Dec 11]
25. Janssens ACJW, Gwinn M, Bradley LA, et al. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008; 82 (3): 593-9
26. Pigozzi F, Rizzo M. Sudden death in competitive athletes. Clin Sports Med 2008; 27 (1): 153-81
27. Trusty JM, Beinborn DS, Jahangir A. Dysrhythmias and the athlete. AACN Clin Issues 2004 Jul-Sep; 15 (3): 432-48
28. Garratt CJ. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. Heart 2008 Apr 1; 94 (4): 502-7
29. Jordan BD, Relkin NR, Ravdin LD, et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 1997 Jul 9; 278 (2): 136-40
30. McCrory P. Boxing and the risk of chronic brain injury. BMJ 2007 Oct 20; 335 (7624): 781-2
31. Shickle D, Chadwick R. The ethics of screening: is 'screeningitis' an incurable disease? J Med Ethics 1994 Mar 1; 20 (1): 12-8
32. Gillon R. Ethics needs principles - four can encompass the rest - and respect for autonomy should be 'first among equals'. J Med Ethics 2003 Oct 1; 29 (5): 307-12
33. Murray T. Genetic exceptonalism and future diaries: is genetic information different from other medical information? In: Rothstein MA, editor. Genetic secrets: protecting privacy and confidentiality in the genetic era. New Haven (CT): Yale University Press, 1997: xvi, 511
34. Yesley MS. Genetic privacy, discrimination, and social policy: challenges and dilemmas. Microb Comp Genomics 1997; 2 (1): 19-35